OVIOS Announces Limited-Time 40% New Year Promotion on Its Flagship U-Shaped Sectional Sofa

OVIOS Announces Limited-Time 40% New Year Promotion on Its Flagship U-Shaped Sectional Sofa GlobeNewswire December 29, 2025 Los Angeles, California, Dec. 28, 2025 (GLOBE NEWSWIRE) — As the New Year approaches, OVIOS, the global home brand celebrated for merging modern design with everyday comfort, invites families to begin 2026 surrounded by warmth and ease. OVIOS […]

LiuGong Launches E-Intelligence Brand, Redefining Green Construction Machinery Through Full-Lifecycle Value

Last month, LiuGong (000528.SZ) officially unveiled its new E-Intelligence brand at the 2025 Global Dealer Conference and 11•26 Global Customer Day held in Liuzhou. The global launch marks a major milestone in LiuGong's green transformation and its next phase of sustainable development. Centered on the brand manifesto “FORWARD GREEN, POWER THE EXTREMES,” the launch underscores

Festive Season Isolation: How Eczema Is Keeping Singaporeans From Gatherings

Medical Channel Asia's ongoing eczema survey reveals how chronic itch drives withdrawal, emotional strain, and missed celebrations during a period traditionally associated with connection and joy. For many, the festive season is marked by reunions, shared meals and long-awaited gatherings. For Mr Li, however, it often comes with apprehension. Festive periods tend to disrupt the

CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND) applications to the National Medical Products Administration (NMPA) for its allogeneic BCMA-targeted CAR-T cell therapy product, CT0596. The applications seek to initiate two corresponding Phase Ib/â…i clinical trials

Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics

(HKSE:6628),(TAI:6589),(TAI:6589.TW), PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) — Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announced it has entered into a strategic collaboration and non-exclusive licensing agreement with EirGenix Inc. (“EirGenix”) (TWSE:

Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics

Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics GlobeNewswire December 29, 2025 PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) — Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research,

Synopsys 48 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuits Against Synopsys, Inc. – SNPS

NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / December 28, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have December 30, 2025 to file lead plaintiff applications in securities class action lawsuits against Synopsys,

Scroll to Top